The National Times - Stock markets hit record highs on easing AI concerns

Stock markets hit record highs on easing AI concerns


Stock markets hit record highs on easing AI concerns
Stock markets hit record highs on easing AI concerns / Photo: © AFP

Stock markets in Asia and Europe reached record highs Wednesday on easing worries about the AI sector which many see as overvalued and a threat to several industries.

Change text size:

Seoul, Tokyo, London, and Paris exchanges each beat their previous intraday highs, also in reaction to well-received company updates.

Global equities gained "as the apocalyptic AI narrative takes a small step back", noted Matt Britzman, senior equity analyst at Hargreaves Lansdown.

Tech shares jumped having rebounded Tuesday on Wall Street.

Investors adopted a more sanguine view following a presentation by AI company Anthropic that emphasised the compatibility of its technology with existing programs.

A weekend report by Citrini Research showed how certain sectors, from financial to food delivery firms, could be at risk from new AI tools.

Focus later Wednesday will be on the release of earnings from chip behemoth Nvidia, with analysts saying they could have an outsized impact on markets.

"Put simply, meeting earnings expectations is unlikely to be enough to drive the stock higher, especially if conservative guidance reinforces some traders' fears that demand for AI (capital expenditure) may be downshifting," warned City Index analyst Matt Weller.

A rally on Wall Street's three main bourses provided a healthy lead for equities across Asia, which has enjoyed a lift from the US Supreme Court's ruling against a swath of President Donald Trump's tariffs.

Seoul's Kospi topped 6,000 points for the first time, led once again by chip titans Samsung and SK hynix. The index has surged more than 40 percent this year, having rallied 76 percent in 2025.

Tokyo piled on more than two percent to hit a new peak, with tech firms Advantest and Tokyo Electron among the best performers.

In Europe, shares in HSBC jumped six percent nearing midday after the global bank posted better-than-expected 2025 earnings.

Elsewhere, the yen retreated further against the dollar on media reports that Japanese Prime Minister Sanae Takaichi told Bank of Japan boss Kazuo Ueda of her concern about hiking interest rates further.

Oil prices rose as Iran dismissed US claims about its missile programme as "big lies", after Trump said Tehran was developing missiles that could strike the United States.

In his State of the Union address Tuesday, Trump accused Tehran of "sinister nuclear ambitions" as Washington ups the pressure with a massive military deployment around the Gulf.

The two foes are scheduled to meet for a third round of talks on Thursday in the Swiss city of Geneva in an effort to reach a diplomatic solution.

- Key figures at around 1130 GMT -

London - FTSE 100: UP 1.0 percent at 10,784.90 points

Paris - CAC 40: UP 0.3 percent at 8,543.95

Frankfurt - DAX: UP 0.4 percent at 25,085.10

Tokyo - Nikkei 225: UP 2.2 percent at 58,583.12 (close)

Hong Kong - Hang Seng Index: UP 0.7 percent at 26,765.72 (close)

Shanghai - Composite: UP 0.7 percent at 4,147.23 (close)

New York - Dow: UP 0.8 percent at 49,174.50 (close)

Dollar/yen: UP at 156.77 yen from 155.74 yen on Tuesday

Euro/dollar: DOWN at $1.1772 from $1.1783

Pound/dollar: DOWN at $1.3496 from $1.3508

Euro/pound: UP at 87.26 pence from 87.23 pence

Brent North Sea Crude: UP 0.5 percent at $70.92 per barrel

West Texas Intermediate: UP 0.4 percent at $65.87 per barrel

G.Waters--TNT

Featured

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Could gas prices return to 2022 highs on US-Iran war?

European gas prices have more than doubled owing to the US-Iran war, just as Europe needs to replenish its reserves ahead of winter.

Change text size: